Shimadzu : Verification of Alzheimer detection method – Estimation of intracerebral amyloid in blood
Shimadzu Corporation
Australian Alzheimer’s Disease Research Organization AIBL
(Australian Imaging, Biomarker & Lifestyle Flagship Study of Aging),
Kyoto University,
The University of Tokyo,
Tokyo Metropolitan Health and long-life medical center,
Kinki University
Using Alzheimer’s lesion detection method, we started analyzing about 2,000 blood specimens.
As a commissioned research and development of the Japan Medical Research and Development Organization (AMED), we verify the accuracy and usefulness of the method diversely.
Sample measurement is scheduled to be completed at the end of March 2019.
Features
The degree of amyloid accumulation in the brain is estimated from only 0.5 mL of blood.
Contributing to the development of radical remedies and preventive methods for Alzheimer’s disease that do not exist yet.
2019 | News | Shimadzu Corporation